Account
82.5 Communications wins creative mandate from De Beers
Mumbai: 82.5 Communications has won the creative mandate from De Beers Group to further ignite the passion for natural diamonds among Indian consumers.
Recognising the immense growth potential within the Indian market, De Beers aims to strengthen the emotional connection consumers have with diamonds, by emphasising the rarity, preciousness, and enduring value of natural diamonds.
“As a leader in the diamond industry, De Beers is focusing on growing the category,” said De Beers Group global SVP Shweta Harit. “Natural diamonds are rare and precious natural treasures with enduring value and we at De Beers are committed to connecting people to their unique attributes with our promotional campaigns. And this effort will be holistic – it will involve reaching out to consumers, working very closely with retailers, partnering with jewellery bodies, and empowering the entire industry. We are happy to have 82.5 with us in this journey”.
De Beers’ arsenal that helps in category development includes proprietary diamond verification technology to support the assurance of the authenticity of its products, and technologies that help in tracing diamonds to their source.
82.5 Communications CEO Kiran Ramamurthy added, “This isn’t just about creating compelling advertising; it’s also about understanding the nuances of the jewellery retail landscape and enabling effective retailer communication, and ultimately, driving tangible business impact for an entire category. We are honored that De Beers has entrusted this large a responsibility to us.”
82.5 Communications – South, executive VP & branch head, Naveen Raman added, “We are excited to partner with De Beers, a brand synonymous with luxury, heritage, and unparalleled craftsmanship. Together, we look forward to shaping narratives that will resonate with a new generation of diamond lovers.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
